Style | Citing Format |
---|---|
MLA | Vajdi M, Khorvash F, Askari G. "The Effects of Inulin Supplementation on Clinical Indices, Oxidative Stress and Inflammatory Biomarkers in Women With Migraine: A Double-Blind, Placebo-Controlled, Randomized Trial." Journal of Functional Foods, vol. 121, no. , 2024, pp. -. |
APA | Vajdi M, Khorvash F, Askari G (2024). The Effects of Inulin Supplementation on Clinical Indices, Oxidative Stress and Inflammatory Biomarkers in Women With Migraine: A Double-Blind, Placebo-Controlled, Randomized Trial. Journal of Functional Foods, 121(), -. |
Chicago | Vajdi M, Khorvash F, Askari G. "The Effects of Inulin Supplementation on Clinical Indices, Oxidative Stress and Inflammatory Biomarkers in Women With Migraine: A Double-Blind, Placebo-Controlled, Randomized Trial." Journal of Functional Foods 121, no. (2024): -. |
Harvard | Vajdi M, Khorvash F, Askari G (2024) 'The Effects of Inulin Supplementation on Clinical Indices, Oxidative Stress and Inflammatory Biomarkers in Women With Migraine: A Double-Blind, Placebo-Controlled, Randomized Trial', Journal of Functional Foods, 121(), pp. -. |
Vancouver | Vajdi M, Khorvash F, Askari G. The Effects of Inulin Supplementation on Clinical Indices, Oxidative Stress and Inflammatory Biomarkers in Women With Migraine: A Double-Blind, Placebo-Controlled, Randomized Trial. Journal of Functional Foods. 2024;121():-. |
BibTex | @article{ author = {Vajdi M and Khorvash F and Askari G}, title = {The Effects of Inulin Supplementation on Clinical Indices, Oxidative Stress and Inflammatory Biomarkers in Women With Migraine: A Double-Blind, Placebo-Controlled, Randomized Trial}, journal = {Journal of Functional Foods}, volume = {121}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Vajdi M AU - Khorvash F AU - Askari G TI - The Effects of Inulin Supplementation on Clinical Indices, Oxidative Stress and Inflammatory Biomarkers in Women With Migraine: A Double-Blind, Placebo-Controlled, Randomized Trial JO - Journal of Functional Foods VL - 121 IS - SP - EP - PY - 2024 ER - |